Back

Berberine

Lowering fasting glucose and HbA1c in type 2 diabetes

Evidence · Grade DSafety · Use with caution
Meta-analysis availableHuman trial evidenceTraditional useSafety cautionInteraction riskNeeds more research

A plant alkaloid often called "nature's metformin" for its blood-sugar lowering effects.

Berberine is an isoquinoline alkaloid extracted from plants like Berberis, goldenseal, and Oregon grape. It has been studied extensively for glucose metabolism, lipid regulation, and gut health.

Quick answer

What it is: Berberine is an isoquinoline alkaloid extracted from plants like Berberis, goldenseal, and Oregon grape.

May support:Metabolic Syndrome, Hypertension, Prediabetes, Insulin Resistance, Obesity, High Cholesterol, H. pylori Infection, Non-Alcoholic Fatty Liver Disease (NAFLD), High Blood Pressure, Non-Alcoholic Fatty Liver Disease (NAFLD), Liver Disease, Type 2 Diabetes, Atherosclerosis, Acne, PCOS, SIBO

Evidence:Evidence · Grade D

Safety:Safety · Use with caution

Evidence Summary

Evidence · Grade D

Evidence for berberine's effects includes data from randomized controlled trials, meta-analyses, and extensive preclinical research. These studies have frequently explored its potential in metabolic syndrome components, including glucose and lipid regulation, and appear to support its current 'B' evidence grade. While promising, a definitive consensus on its broad clinical application awaits further large-scale, high-quality human studies.

Last reviewed · Jun 2026

Have you tried Berberine?

Vote in 5 seconds. Add details if you want.

Your experience for Metabolic Syndrome:

Commonly Combined With

Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.

Community signal breakdown

Where this remedy is being discussed across the web and community.

People Like Me insights

As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.

Community Discussions

What people say about Berberine

Search on Reddit →

Latest News

Latest news on Berberine

More on Google News →

Health Videos

Health videos on Berberine

More on YouTube

Why It Works

Activates AMP-activated protein kinase (AMPK), improving insulin sensitivity, glucose uptake, and lipid metabolism.

How it works in more detail

Berberine appears to modulate multiple molecular targets, including activation of AMP-activated protein kinase (AMPK), which can influence glucose and lipid metabolism. It may also inhibit pro-inflammatory pathways, such as NF-κB, and impact the gut microbiota composition. Preclinical studies suggest it can affect insulin signaling, promote cholesterol efflux, and exhibit antimicrobial properties. The pleiotropic effects of berberine suggest its involvement in regulating various cellular processes related to metabolic and inflammatory conditions.

How to use

Always consult a qualified clinician.

Editorial guidance

Suggested dosage
500 mg, 2–3 times daily with meals (1000–1500 mg/day total)
Research dosage range
500–1500 mg/day administered in divided doses
Typical onset
The onset of effects for berberine may vary, with some metabolic benefits potentially seen over several weeks of consistent use, rather than acute, immediate effects. For certain gastrointestinal applications, effects might be observed more rapidly.
Typical forms
capsule, tablet, powder
Quality markers
A quality berberine product should specify the percentage of berberine alkaloids (e.g., standardized to 97% berberine HCl), indicating extract potency. Third-party testing for purity and contaminants, as well as verification of berberine content, is also a marker of quality. Some formulations enhance bioavailability, which may be a consideration for product selection.
Medication interactions
  • Antidiabetic drugs
  • Anticoagulants
  • Antihypertensive drugs
  • Immunosuppressants (e.g., cyclosporine)
  • CYP450 metabolized drugs
Avoid if
  • Pregnant
  • Breastfeeding
  • Infants or young children
  • Individuals with liver disease
  • Individuals with G6PD deficiency

Community tips

No community tips yet — be the first to share what worked for you.

Suggested dosage

500 mg, 2–3 times daily with meals (1000–1500 mg/day total)

General guidance — discuss specifics with a clinician.

Active medicinal compounds

Berberine (an isoquinoline alkaloid)

Traditional use

Berberine-containing plants have a long history of use in traditional medicine systems. In Traditional Chinese Medicine (TCM), plants like Coptis chinensis (Huang Lian) have been used for centuries to treat gastrointestinal infections, diarrhea, and inflammatory conditions. Ayurvedic medicine also utilizes Berberis aristata (Daruharidra) for similar purposes, as well as for supporting liver health and managing blood sugar.

Safety

Safety warnings

May cause GI upset. Interacts with many medications via CYP3A4. Avoid in pregnancy and breastfeeding.

Avoid if

  • Pregnant
  • Breastfeeding
  • Infants or young children
  • Individuals with liver disease
  • Individuals with G6PD deficiency

Medication interactions

  • Antidiabetic drugs
  • Anticoagulants
  • Antihypertensive drugs
  • Immunosuppressants (e.g., cyclosporine)
  • CYP450 metabolized drugs

Reported side effects

  • Nausea
  • Diarrhea
  • Constipation
  • Abdominal discomfort
  • Vomiting

General guidance — discuss specifics with a clinician.

Evidence ecosystem

Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.

Overall grade (D)

Evidence for berberine's effects includes data from randomized controlled trials, meta-analyses, and extensive preclinical research. These studies have frequently explored its potential in metabolic syndrome components, including glucose and lipid regulation, and appear to support its current 'B' evidence grade. While promising, a definitive consensus on its broad clinical application awaits further large-scale, high-quality human studies.

Filter by source type

Meta-Analyses(1)

Pooled analyses across multiple human trials.

Very High Quality
  • Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.

    Blais JE, Huang X, Zhao JV · Drugs · 2023 · n=1788

    Berberine is a nutraceutical that can improve lipid metabolism. Berberine may also affect sex hormones and exert sex-specific lipid-modifying effects, which have been overlooked. This study aimed to comprehensively review the efficacy and safety of berberine in adults for the treatment of dyslipidemia with consideration of potential sex disparity. Data Sources We searched Medline, Embase, Wanfang, CNKI, ClinicalTrials.gov, and the WHO International Clinical Trials Registry Platform from inception to 13 December 2022. No language restrictions were applied. This study was registered in PROSPERO (CRD42021293218) prior to completing the literature search. Study Selection Two blinded reviewers assessed studies for inclusion. Eligible studies were randomized controlled trials in adults that compared berberine versus placebo, and measured blood lipids or lipoproteins. Data Extraction and Synthesis Data extraction was performed by two blinded reviewers using a structured form in Covidence. Ris

    Meta-AnalysisPubMedVery High Quality

Randomized Human Trials(2)

Controlled human studies with random assignment.

High Quality
  • Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study).

    Guo H, Lu S, Zhang J, Chen C, Du Y, Wang K · Frontiers in pharmacology · 2023 · n=180

    Introduction: Small intestinal bacterial overgrowth (SIBO) leads to non-specific abdominal discomfort and nutrient malabsorption. Currently, rifaximin is widely applied in SIBO based on its antibacterial and non-absorbable nature. Berberine is a natural component of many popular medicine plants that ameliorates intestinal inflammation in humans through its modification of the gut microbiota. Potential effect of berberine to the gut may provide therapeutic target for SIBO. We aimed to evaluate the effect of berberine compared with rifaximin on SIBO patients. Methods: This is an investigator-initiated, single-center, open-label, double-arm randomized controlled trial, termed BRIEF-SIBO (Berberine and rifaximin effects for small intestinal bacterial overgrowth). In total, 180 patients will be recruited and allocated to an intervention group (berberine) and a control group (rifaximin). Each participant will receive one 400 mg drug twice a day (800 mg daily) for 2 weeks. The

    Randomized TrialPubMedHigh Quality
  • Berberine Phospholipid Is an Effective Insulin Sensitizer and Improves Metabolic and Hormonal Disorders in Women with Polycystic Ovary Syndrome: A One-Group Pretest-Post-Test Explanatory Study.

    Rondanelli M, Riva A, Petrangolini G, Allegrini P, Giacosa A, Fazia T · Nutrients · 2021

    Polycystic Ovary Syndrome (PCOS) is the most frequent endocrine disease in females of reproductive age and is characterized by multifactorial unhealthy conditions related to hormonal unbalance and also to dysmetabolism and inflammation. Recently, increasing evidence has shown that natural plant-based products may play a role in PCOS management. The aim of this one-group pretest-post-test explanatory study was to evaluate, in normal-overweight PCOS women with normal menses, the effectiveness of berberine on: Insulin resistance (IR) by Homeostasis Model Assessment (HOMA); Inflammation by C-Reactive Protein (CRP), Tumor Necrosis Factor α (TNF-α); Lipid metabolism; Sex hormone profile and symptoms correlated to hyperandrogenism, such as acne, by Global Acne Grading System (GAGS) and Cardiff Acne Disability Index (CADI); Body composition by DXA. Finally, adverse effects were assessed by liver and kidney functions and creatine phosphokinase (CPK). All these parameters were collec

    Randomized TrialPubMedHigh Quality

Observational Studies(3)

Cohort, case-control, and cross-sectional human studies.

Moderate Quality
  • Pharmacological landscape of endoplasmic reticulum stress: Uncovering therapeutic avenues for metabolic diseases.

    Alotaibi G, Alkhammash A · European journal of pharmacology · 2025

    The endoplasmic reticulum (ER) plays a fundamental role in maintaining cellular homeostasis by ensuring proper protein folding, lipid metabolism, and calcium regulation. However, disruptions to ER function, known as ER stress, activate the unfolded protein response (UPR) to restore balance. Chronic or unresolved ER stress contributes to metabolic dysfunctions, including insulin resistance, non-alcoholic fatty liver disease (NAFLD), and neurodegenerative disorders such as Parkinson's disease and Alzheimer's disease. Recent studies have also highlighted the importance of mitochondria-ER contact sites (MERCs) and ER-associated inflammation in disease progression. This review explores the current pharmacological landscape targeting ER stress, focusing on therapeutic strategies for rare metabolic and neurodegenerative diseases. It examines small molecules such as tauroursodeoxycholic acid (TUDCA) and 4-phenylbutyric acid (4-PBA), repurposed drugs like 17-AAG (17-N-allylamino-17demethoxygeld

    Observational StudyPubMedLow Quality
  • A Comprehensive Review of Herbal Supplements Used for Persistent Symptoms Attributed to Lyme Disease.

    Thompson A, Hynicka LM, Shere-Wolfe KD · Integrative medicine (Encinitas, Calif.) · 2023

    Lyme disease is the most common, tick-borne disease in the USA. While most patients successfully recover with antibiotics, some patients experience persistent symptoms for months to years. Patients who attribute chronic symptoms to Lyme disease commonly use herbal supplements. The complexity, variability in dose and formulation, and lack of data for these herbal compounds make it difficult to assess their efficacy and safety. This review examines the evidence for the antimicrobial activity, safety, and drug-drug interactions of 18 herbal supplements that patients commonly use for treatment of persistent symptoms attributed to Lyme disease. The research team performed a narrative review by searching the PubMed, Embase, Scopus, Natural Medicines databases, and NCCIH website. The search used the keywords for 18 herbal compounds: (1) andrographis (Andrographis paniculate), (2) astragalus (Astragalus propinquus), (3) berberine, (4) cat's claw bark (Uncaria tomentosa), (5) cordyceps (Cordy

    Observational StudyPubMedLow Quality
  • Berberine and lycopene as alternative or add-on therapy to metformin and statins, a review.

    Hedayati N, Oskouei Z, Tabeshpour J, Naeini MB · European journal of pharmacology · 2021

    Nutraceuticals are principally extracted from natural products that are frequently safe and well-tolerated. Lycopene and berberine are natural plants with a wide range of beneficial effects including protective activities against metabolic disorders such as diabetes and cardiovascular diseases. These compounds might be considered technically more as a drug than a nutraceutical and could be prescribed as a product. However, further studies are needed to understand if these supplements could affect metabolic syndrome outcomes. Even if nutraceuticals exert a prophylactic activity within the body, their bioactivity and bioavailability have high interindividual variation, and precise assessment of biological function of these bioactive compounds in randomized clinical trials is critical. However, these reports must be interpreted with more considerations due to the low quality of the trials. The aim of this paper is to bring evidence about the management of cardiovascular diseases and diabe

    Observational StudyPubMedLow Quality

Clinical Trial Registries(5)

Registered ongoing or completed trials (ClinicalTrials.gov).

Moderate Quality
  • Helicobacter Pylori Eradication With Berberine Hydrochloride, Lansoprazole, Amoxicillin and Bismuth Versus Clarithromycin Bismuth, Lansoprazole and Amoxicillin: A Randomized, Open-label, Non-inferiority, Phase Ⅳ Trial

    n=566 · NCT02633930 · COMPLETED · COMPLETED

    This study aims at evaluating efficacy and safety of berberine-containing quadruple therapy(berberine, lansoprazole, bismuth and amoxicillin) versus clarithromycin-containing quadruple therapy (clarithromycin,lansoprazole, bismuth and amoxicillin) in H. pylori eradication. It is hypothesized that berberine-containing quadruple therapy is non-inferior to clarithromycin-containing quadruple therapy. Patients with confirmed H. pylori positive status will be randomized to one of the treatments described above. At week 2 and 6 follow-up visits, a urea breath test(UBT) will be performed to confirm eradication.

    Clinical TrialClinicalTrials.govModerate Quality
  • Efficacy and Safety of Berberine in Non-alcoholic Steatohepatitis: a Multicentre, Randomised, Placebo-controlled Trial

    n=120 · NCT03198572 · UNKNOWN · UNKNOWN

    The purpose of this study is to evaluate the efficacy and safety of berberine treatment on Non-alcoholic Steatohepatitis.

    Clinical TrialClinicalTrials.govModerate Quality
  • Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori.

    n=548 · NCT06603688 · UNKNOWN · UNKNOWN

    The aim of this study is to evaluate the efficacy and safety of a quadruple therapy consisting of berberine hydrochloride, minocycline, esomeprazole, and colloidal bismuth tartrate for the first phase eradication of Helicobacter pylori. Assuming that the quadruple therapy of berberine hydrochloride, minocycline, esomeprazole, and colloidal bismuth tartrate is no less effective than the bismuth containing quadruple therapy of amoxicillin and clarithromycin. Patients diagnosed with Helicobacter pylori infection will be randomly assigned to one of the aforementioned treatments. During the 6-week follow-up, urea breath test, rapid urease test, or Helicobacter pylori fecal antigen test will be performed to confirm eradication. The aim of this study is to evaluate the efficacy and safety of a quadruple therapy consisting of berberine hydrochloride, minocycline, esomeprazole, and colloidal bismuth tartrate for the first phase eradication of Helicobacter pylori. Assuming that the quadruple therapy of berberine hydrochloride, minocycline, esomeprazole, and colloidal bismuth tartrate is no less effective than the bismuth containing quadruple therapy of amoxicillin and clarithromycin. Patients diagnosed with Helicobacter pylori infection will be randomly assigned to one of the aforementioned treatments. During the 6-week follow-up, urea breath test, rapid urease test, or Helicobacter pylori fecal antigen test will be performed to confirm eradication.

    Clinical TrialClinicalTrials.govModerate Quality

Evidence Summaries(1)

Curated cross-source summaries (TRIP Database and similar).

High Quality
  • About Herbs, Botanicals & Other Products: Berberine

    Memorial Sloan Kettering Cancer Center

    MSKCC's "About Herbs" resource provides information on berberine, including its purported uses for various conditions and a summary of scientific evidence. It often discusses potential interactions and safety concerns relevant for patients.

    Evidence SummaryMemorial Sloan Kettering Cancer CenterHigh Quality

Limitations: Many human studies on berberine are relatively small, short-term, or exhibit significant heterogeneity in study design, population, and intervention. There is a need for larger, well-designed, long-term randomized controlled trials to confirm preliminary findings. The bioavailability of berberine can also be a limiting factor, and different formulations may influence its efficacy.

Health Voice Perspectives

Independent of evidence grade

Approved mentions from health educators, physicians, and researchers across podcasts, videos, and articles. Educational context only — does not influence the scientific evidence rating above.

  • DB
    Drew Baird· Personal Trainer; Founder, NOVUM PCOS Coaching

    Uses berberine selectively for insulin-resistant clients who need more aggressive blood-sugar support beyond diet and training.

    "Berberine isn't a magic pill, but for the right insulin-resistant client it can move fasting glucose in weeks."
    ·6/4/2026

This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.

Tried Berberine?

Help others see what actually works.